AA
ABBV icon

AlphaMark Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$94K Hold
527
0.04% 181
2024
Q3
$104K Buy
527
+3
+0.6% +$592 0.04% 271
2024
Q2
$90K Sell
524
-66
-11% -$11.3K 0.03% 291
2024
Q1
$107K Buy
590
+73
+14% +$13.2K 0.04% 269
2023
Q4
$80K Buy
517
+29
+6% +$4.49K 0.03% 294
2023
Q3
$73K Buy
488
+4
+0.8% +$598 0.03% 289
2023
Q2
$65K Sell
484
-96
-17% -$12.9K 0.03% 198
2023
Q1
$92K Sell
580
-46
-7% -$7.3K 0.04% 172
2022
Q4
$101K Sell
626
-172
-22% -$27.8K 0.05% 148
2022
Q3
$107K Buy
798
+4
+0.5% +$536 0.05% 145
2022
Q2
$122K Buy
794
+3
+0.4% +$461 0.06% 134
2022
Q1
$128K Sell
791
-96
-11% -$15.5K 0.05% 154
2021
Q4
$120K Sell
887
-146
-14% -$19.8K 0.04% 173
2021
Q3
$111K Buy
1,033
+278
+37% +$29.9K 0.04% 176
2021
Q2
$85K Buy
755
+4
+0.5% +$450 0.03% 191
2021
Q1
$81K Buy
751
+5
+0.7% +$539 0.03% 187
2020
Q4
$80K Buy
746
+4
+0.5% +$429 0.03% 176
2020
Q3
$65K Sell
742
-346
-32% -$30.3K 0.03% 179
2020
Q2
$107K Buy
1,088
+504
+86% +$49.6K 0.05% 140
2020
Q1
$44K Buy
584
+4
+0.7% +$301 0.02% 192
2019
Q4
$51K Buy
580
+4
+0.7% +$352 0.02% 197
2019
Q3
$44K Sell
576
-3,153
-85% -$241K 0.02% 204
2019
Q2
$271K Sell
3,729
-452
-11% -$32.8K 0.12% 78
2019
Q1
$337K Buy
4,181
+86
+2% +$6.93K 0.14% 71
2018
Q4
$378K Buy
4,095
+5
+0.1% +$462 0.18% 73
2018
Q3
$387K Sell
4,090
-195
-5% -$18.5K 0.16% 94
2018
Q2
$397K Buy
4,285
+201
+5% +$18.6K 0.16% 90
2018
Q1
$387K Sell
4,084
-499
-11% -$47.3K 0.17% 85
2017
Q4
$443K Sell
4,583
-349
-7% -$33.7K 0.17% 83
2017
Q3
$438K Sell
4,932
-24
-0.5% -$2.13K 0.19% 75
2017
Q2
$359K Sell
4,956
-250
-5% -$18.1K 0.15% 82
2017
Q1
$339K Buy
5,206
+1,006
+24% +$65.5K 0.16% 84
2016
Q4
$263K Hold
4,200
0.14% 90
2016
Q3
$265K Hold
4,200
0.13% 90
2016
Q2
$260K Hold
4,200
0.15% 86
2016
Q1
$240K Buy
4,200
+1,075
+34% +$61.4K 0.13% 86
2015
Q4
$185K Buy
+3,125
New +$185K 0.09% 91
2015
Q3
Sell
-8,000
Closed -$538K 290
2015
Q2
$538K Buy
+8,000
New +$538K 0.3% 69
2013
Q3
Sell
-8,378
Closed -$346K 309
2013
Q2
$346K Buy
+8,378
New +$346K 0.21% 81